about
Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.Web based pathology assessment in RTOG 98-04.Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results.A phase II trial of carboplatin for intraocular retinoblastoma.Breast cancer version 3.2014.RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.Postmastectomy CT-based electron beam radiotherapy: dosimetry, efficacy, and toxicity in 118 patients.Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: a prospective outcomes analysis.(106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer.Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17What Is the Optimum Timing of Postmastectomy Radiotherapy in Two-Stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant?The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast CancerFractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.Partial breast radiation for early-stage breast cancer.Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.Radiation therapy for duct carcinoma in situ: who needs radiation therapy, who doesn't?Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.NCCN Practice Guidelines for Breast Cancer.Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity.RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis.Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma.Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis.Patterns of utilization of adjuvant radiotherapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center.NCCN Guidelines Insights: Breast Cancer, Version 1.2017.Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: practice patterns at National Comprehensive Cancer Network institutions.NCCN Guidelines Insights Breast Cancer, Version 1.2016.The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years.Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.Breast reconstruction combined with radiation therapy: long-term risks and factors related to decision making.Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes.Do metallic ports in tissue expanders affect postmastectomy radiation delivery?Intensity-modulated radiotherapy technique for three-field breast treatment.Intensity-modulated tangential beam irradiation of the intact breast.Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results.
P50
Q33765776-3EC0A150-A868-494E-B4FD-A2583726AE2DQ34092275-D220B97D-A217-4168-9022-480DC3236C5FQ34192623-AA09A46C-93E4-479F-A242-BE318F979410Q34575605-50530347-0D87-494D-A0EE-2C6757A9FE2EQ34661225-858CEE26-1AE7-49FB-B462-85BB79DEAC51Q35102484-2AB55BE6-29B1-4634-9C3C-AE5CDB5F9D7CQ35935702-900CD2FB-CDF4-4666-BA19-C0430B3B5C59Q36305389-4AB34117-1D56-4D8E-A802-BCDAFC05BE35Q36331200-8523C908-0E2D-40FF-B90A-DBE68E61EDE1Q36830694-1F60A05A-E530-4D96-A06F-9D969B72F5E5Q36942247-019DE0A6-E3DF-4857-9EC3-AAEC9A74000FQ36951718-B723312A-E917-4226-AE50-047A7C968688Q37017475-8DAD8E14-4299-40F5-B81F-ED07A1A69931Q37216200-5C3BA8E8-810D-4C89-929C-814D041B17C5Q37217746-56957E38-1B05-4AE6-A059-F198157445A9Q37383075-29FF9B60-475F-4B25-8CCF-CE1D93D009FEQ37773606-763A9C69-A983-4A31-9335-EDC6F8F10529Q37950788-ABADE909-6EE2-4784-8B29-DFA2E5585814Q38023589-AFF257B2-6CB7-432F-A68F-40F75B30F735Q38126603-D9328DE5-49DA-4695-9915-B677AA997C85Q38466484-1759C9A9-FA1D-4D66-A174-E8363017BE1DQ38672704-C030879A-B11D-4252-BE41-7B6F2863FE61Q40725293-FA53F2C9-47A5-4F67-9014-B4A6B2C467E0Q41634028-C1C59E2C-BDE4-4C2A-9D48-D5A0AAA821C0Q44988623-8AEB859E-A1A4-4A0C-9C5C-B29F1A3D54FBQ45056949-8EB61135-3859-446F-A3CF-442A9BA55643Q45161465-18C284B5-AD47-4AA7-9F75-43DAC658E006Q46719304-01656DB0-EC26-4583-9433-1D620CD5668AQ47579286-2B054C02-36A3-42C3-80F0-F1DB53CEFC00Q47587780-DD1F9D60-FD18-4BF3-BDA6-276838FB5142Q47640084-2ABC480E-20F2-48EF-8F68-C32DE6C5C120Q48061158-96D6E726-760A-4FAB-BD28-F49C33666988Q48273329-8C6BF88D-BB7C-4C05-BF58-3C03CF3C9D90Q48481125-8140BAF5-C885-4F3B-9138-9C70577F46C4Q50912537-9FB69065-34CD-435E-BE25-8E0C559DC556Q51147182-0548E0BA-D5B0-45CE-BB47-9A0FE4E1379DQ51970209-C000039E-60E3-4F17-BE14-1A9A818A1747Q52208587-52CE6ECC-93D2-4E15-B675-94B0108C8D87Q52822443-856DC51C-116A-40D0-9EF7-4720ECC9FF70Q53195906-64D5084C-9282-4583-9213-CA65E77BFBF0
P50
description
researcher
@en
wetenschapper
@nl
name
Beryl McCormick
@en
Beryl McCormick
@nl
type
label
Beryl McCormick
@en
Beryl McCormick
@nl
prefLabel
Beryl McCormick
@en
Beryl McCormick
@nl
P106
P31
P496
0000-0002-4550-0565